Tag Archives: lawsuit

101 Million dollars paid to child victim of MMR vacine

$101 Million Dollar Vaccine Injury Award for Encephalopathy from MMR Vaccine

(July 17th, 2018 – SARASOTA, FL) — Attorneys at Maglio Christopher & Toale, P.A. negotiated a $101 million dollar settlement for an infant who suffered a severe reaction to the Measles Mumps Rubella (MMR) vaccine.

O.R.* was a one-year-old healthy baby girl who was already walking and climbing.  On February 13, 2013, she received vaccinations for Measles Mumps Rubella (MMR), Hepatitis A, Haemophilus Influenzae type B (Hib), Prevnar (pneumonia), and Varicella (chickenpox).  That evening, the mother noticed baby O.R. was irritable and feverish. After a call to the pediatrician, the doctor advised Mom to give her Tylenol and Benadryl. The fever continued for several days and on the evening before the baby’s scheduled pediatrician visit, O.R. began having severe seizures. She was rushed to the emergency room.  Baby O.R. went into cardiac and respiratory arrest and doctors placed her on a ventilator.

The seizures and cardiac arrest left O.R. with a severe brain injury, encephalopathy, cortical vision impairment, truncal hypotonia (low muscle tone), and kidney failure. After months of treatment at the hospital, baby O.R. finally went home, but her disabilities require specialized medical care and supervision around the clock for the rest of her life.  READ MORE…

 

 

MUMPS FRAUD: Whistleblower files to compel

Doctor in his practice with syringe and a little girl child, she is very concerned and fearful of the treatment, and very understandably so

Two former Merck & Co Inc scientists accusing the drugmaker of falsifying tests of its exclusive mumps vaccine said in a court filing on Monday that Merck is refusing to respond to questions about the efficacy of the vaccine.

Attorneys at Constantine Cannon, who represent the scientists, asked U.S. Magistrate Judge Lynne Sitarski of the Eastern District of Pennsylvania to compel Merck to respond to their discovery request, which asks the company to give the efficacy of the vaccine as a percentage.

Instead of answering the question, the letter said, Merck has been consistently evasive, using “cut-and-paste” answers saying it cannot run a new clinical trial to determine the current efficacy, and providing only data from 50 years ago.

“Merck should not be permitted to raise as one of its principal defenses that its vaccine has a high efficacy, which is accurately represented on the product’s label, but then refuse to answer what it claims that efficacy actually is,” the letter said.

A representative of Merck could not immediately be reached for comment. (See: Merck accused of stonewalling in mumps vaccine antitrust lawsuit)

Read more…

Brain-Damaged Victims of Swine Flu Vaccine Win $63 Million Lawsuit

glaxosmithkline_raises_853_million_by_halving_stake_in_south_african_drugmaker

GlaxoSmithKline (GSK) is in the news again making headlines after having to settle another major lawsuit bringing the latest total to over $9.1 billion since 2003.

This time, it is due to GSK’s product Pandemrix, which was the swine flu vaccine forced upon the public during the pandemic of 2009 (which is argued by some to have been fake). As the victims are being compensated in the U.K., the same neurological mechanisms that damaged the children in the lawsuit are still potentially at work in the confirmed excitotoxicity that takes place after many vaccine injections.  Read more…